K. Brown

发表

Incidence of Peptic Ulcer Bleeding in the US Pediatric Population

P. Lundborg, K. Brown, J. Levinson, 2012, Journal of pediatric gastroenterology and nutrition.

Intestinal Interleukin-13 in Pediatric Inflammatory Bowel Disease Patients

R. Baldassano, D. von Allmen, E. Ruchelli, 2004, Inflammatory bowel diseases.

NSAID-Associated Adverse Effects and Acid Control Aids to Prevent Them

K. Brown, J. Naesdal, 2006, Drug safety.

A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Sirukumab in the Treatment of Giant Cell Arteritis

D. Blockmans, R. Luqmani, W. Schmidt, 2020, Rheumatology and Therapy.

Safety and steroid-sparing experience using infliximab for Crohn's disease at a pediatric inflammatory bowel disease center.

R. Baldassano, M. Stephens, P. Mamula, 2003 .

Colitis in Infancy and Childhood

R. Baldassano, L. Albenberg, P. Mamula, 2014 .

Severity of Esophageal Eosinophilia Predicts Response to Conventional Gastroesophageal Reflux Therapy

E. Ruchelli, K. Brown, C. Liacouras, 1999, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

A randomised, placebo-controlled study of RIPK1 inhibitor GSK2982772 in patients with active ulcerative colitis

P. Tak, S. Hawkins, D. Tompson, 2021, BMJ open gastroenterology.

Intestinal cytokines in children with pervasive developmental disorders

A. Mulberg, E. Ruchelli, K. Brown, 2003, American Journal of Gastroenterology.

Janus kinase 1 inhibitor INCB054707 for patients with moderate‐to‐severe hidradenitis suppurativa: results from two phase II studies

J. Kirby, I. Hamzavi, M. Howell, 2022, The British journal of dermatology.

BJD_20969 803..813

J. Kirby, I. Hamzavi, M. Howell, 2022 .

Lymphocyte trafficking, survival and proliferation.

K. Brown, 2002, Trends in immunology.

Safety and Steroid-Sparing Experience Using Infliximab for Crohn's Disease at a Pediatric Inflammatory Bowel Disease Center

R. Baldassano, M. Stephens, P. Mamula, 2003, American Journal of Gastroenterology.

Infliximab as a Novel Therapy for Pediatric Ulcerative Colitis

R. Baldassano, D. Piccoli, P. Mamula, 2002, Journal of pediatric gastroenterology and nutrition.

Lamina Propria and Circulating Interleukin-8 in Newly and Previously Diagnosed Pediatric Inflammatory Bowel Disease Patients

R. Baldassano, E. Ruchelli, K. Brown, 2007, Digestive Diseases and Sciences.

Lamina propria and circulating interleukin-6 in newly diagnosed pediatric inflammatory bowel disease patients.

R. Baldassano, Susan J. Back, D. Piccoli, 2002 .

Lamina propria and circulating interleukin-6 in newly diagnosed pediatric inflammatory bowel disease patients

R. Baldassano, Susan J. Back, D. Piccoli, 2002, American Journal of Gastroenterology.

Safety, pharmacokinetic and pharmacodynamic properties of TV-1106, a long-acting GH treatment for GH deficiency

A. Sakov, O. Spiegelstein, K. Brown, 2015, European journal of endocrinology.

The clinical utility of CA 19-9 in pancreatic adenocarcinoma: diagnostic and prognostic updates.

M A Firpo, K. Boucher, S. Mulvihill, 2013, Current molecular medicine.

Clinical trial: esomeprazole for moderate‐to‐severe nighttime heartburn and gastro‐oesophageal reflux disease‐related sleep disturbances

C. Hwang, K. Brown, D. Johnson, 2010, Alimentary pharmacology & therapeutics.

Effect of Esomeprazole on Nighttime Heartburn and Sleep Quality in Patients with GERD: A Randomized, Placebo-Controlled Trial

T. Roth, D. Johnson, W. Orr, 2005, The American Journal of Gastroenterology.

Long-term safety and efficacy of sirukumab for patients with rheumatoid arthritis who previously received sirukumab in randomised controlled trials (SIRROUND-LTE)

Yoshiya Tanaka, B. Hsu, C. Bingham, 2021, RMD Open.

Inflammatory bowel disease in children 5 years of age and younger

R. Baldassano, D. Piccoli, P. Mamula, 2002, American Journal of Gastroenterology.

Colitis in Childhood

R. Baldassano, P. Russo, K. Brown, 2004 .

Hyperendemic rheumatic heart disease in a remote Australian town identified by echocardiographic screening.

A. Ralph, G. Whalley, K. Brown, 2020, The Medical journal of Australia.

Healing of Gastric Ulcers with Esomeprazole Versus Ranitidine in Patients Who Continued to Receive NSAID Therapy: A Randomized Trial

J. Johanson, K. Brown, J. Goldstein, 2005, The American Journal of Gastroenterology.

Phase I, multicenter, randomized, open-label study evaluating the pharmacokinetics and safety profile of repeated once-daily doses of intravenous esomeprazole in children 0 to 17 years of age.

P. Lundborg, G. Långström, G. Davidson, 2012, Clinical therapeutics.

Clinical Trials (Industry/Regulatory Perspective)

A. Mulberg, K. Brown, A. P. Johnson, 2017 .

Failure of single-toxin assays to detect Clostridium difficile infection in pediatric inflammatory bowel disease

R. Baldassano, D. Piccoli, P. Mamula, 2001, American Journal of Gastroenterology.

A phase II study of laquinimod in Crohn's disease

A. Sakov, P. Rutgeerts, G. D'Haens, 2014, Gut.

P386 Pharmacokinetics of laquinimod in patients with active moderate to severe Crohn's disease

P. Rutgeerts, G. D'Haens, W. Sandborn, 2014 .

A phase II study of laquinimod in Crohn's disease

A. Sakov, P. Rutgeerts, G. D'Haens, 2014, Gut.

Incidence of Peptic Ulcer Bleeding in the US Pediatric Population

P. Lundborg, K. Brown, J. Levinson, 2012, Journal of pediatric gastroenterology and nutrition.